Orthofix Medical Inc (OFIX)

Currency in USD
10.77
-0.27(-2.45%)
Closed·
After Hours
10.62-0.15(-1.39%)
·
OFIX Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
Earnings results expected in 3 days
Fair Value
Day's Range
10.7510.95
52 wk Range
10.2420.73
Key Statistics
Prev. Close
11.04
Open
10.92
Day's Range
10.75-10.95
52 wk Range
10.24-20.73
Volume
332.76K
Average Volume (3m)
426.13K
1-Year Change
-31.64%
Book Value / Share
11.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OFIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
22.30
Upside
+107.06%
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Orthofix Medical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Orthofix Medical Inc Company Profile

Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Orthofix Medical Inc SWOT Analysis


Financial Resilience
Orthofix outperforms analyst expectations in Q4 2024, with revenue of $215.7 million and EBITDA of $23.9 million, showcasing its market adaptability
Strategic Pivot
Discover how Orthofix's M6-C disc phase-out and new product launches are poised to drive revenue growth and strengthen its market position
Growth Trajectory
Explore Orthofix's ambitious targets: revenue CAGR of 6.5-7.5% through 2027 and mid-teens adjusted EBITDA, signaling confidence in long-term prospects
Market Valuation
Despite conservative 2025 guidance, Orthofix's stock appears undervalued based on Fair Value estimates, presenting potential upside for investors
Read full SWOT analysis

Orthofix Medical Inc Earnings Call Summary for Q1/2025

  • Orthofix Q1 2025 EPS of -$1.35 missed -$0.55 forecast; revenue of $193.6M beat $191.01M estimate; shares fell 10.86% pre-market
  • Full-year net sales guidance of $800-$816M implies 5% constant currency growth; non-GAAP adjusted EBITDA projected at $82-$86M
  • Company focuses on product innovation with new launches planned; aims to optimize operations for $3M annual savings
  • Restructuring costs and distributor transitions expected to impact short-term revenue; pricing pressures from hospital account joint ventures noted
  • Management confident in long-term growth strategies despite challenges; positive free cash flow anticipated in 2025
Last Updated: 06/05/2025, 14:48
Read Full Transcript

Compare OFIX to Peers and Sector

Metrics to compare
OFIX
Peers
Sector
Relationship
P/E Ratio
−2.9x−2.6x−0.5x
PEG Ratio
0.320.030.00
Price/Book
0.9x2.8x2.6x
Price / LTM Sales
0.5x2.4x3.2x
Upside (Analyst Target)
113.4%66.8%45.7%
Fair Value Upside
Unlock14.6%8.6%Unlock

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 22.30
(+107.06% Upside)

Earnings

Latest Release
May 06, 2025
EPS / Forecast
-1.35 / -0.55
Revenue / Forecast
193.60M / 191.01M
EPS Revisions
Last 90 days

OFIX Income Statement

People Also Watch

6.360
AMPX
-8.23%
10.05
DYN
+2.03%
15.080
ZETA
-3.64%
11.110
ZVRA
0.00%
36.36
SRRK
-1.86%

FAQ

What Stock Exchange Does Orthofix Trade On?

Orthofix is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Orthofix?

The stock symbol for Orthofix is "OFIX."

What Is the Orthofix Market Cap?

As of today, Orthofix market cap is 421.98M.

What Is Orthofix's Earnings Per Share (TTM)?

The Orthofix EPS (TTM) is -3.72.

When Is the Next Orthofix Earnings Date?

Orthofix will release its next earnings report on 04 Aug 2025.

From a Technical Analysis Perspective, Is OFIX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Orthofix Stock Split?

Orthofix has split 0 times.

How Many Employees Does Orthofix Have?

Orthofix has 1616 employees.

What is the current trading status of Orthofix (OFIX)?

As of 02 Aug 2025, Orthofix (OFIX) is trading at a price of 10.77, with a previous close of 11.04. The stock has fluctuated within a day range of 10.75 to 10.95, while its 52-week range spans from 10.24 to 20.73.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.